Hamilton Michael
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.
Treat Endocrinol. 2002;1(1):21-36. doi: 10.2165/00024677-200201010-00003.
The prevalence of overweight and obesity is increasing worldwide. During the last two decades, the prevalence of adults in the higher body mass index (BMI) categories in the US has increased the most, as much as 300% for those with a BMI above 40kg/m2. In children and adolescents, a doubling of the prevalence of severe overweight poses a serious health risk to future generations of young adults who may develop chronic diseases normally associated with aging. The simple definition of obesity, an imbalance between energy intake and energy expenditure, ignores the complexity of, and largely unknown interactions between, genes, food intake and physical activity, which together determine bodyweight and fat distribution. Although the etiology and manifestations of overweight and obesity are complex, the assessment of overweight and obesity requires only an accurate measurement of bodyweight, height and abdominal circumference, as well as a history and physical examination attuned to the morbidities that commonly accompany overweight and obesity such as diabetes mellitus, hypertension, dyslipidemia and sleep apnea. The treatment of patients with overweight and obesity continues to be based on changes to diet and physical activity. Simple behavior modification techniques are within the reach of busy clinicians. The additional use of available bodyweight reduction medications can reliably lead to a 5 to 10% reduction from initial bodyweight, a loss that has been shown to provide significant health benefit. The use of meal replacements has also been shown to be effective and is probably an under-appreciated treatment resource. Surgery is the most successful treatment for those with severe obesity and should be discussed as an option for those in the appropriate bodyweight categories. Because societal trends favor the greater intake of calorie-dense foods and less physical activity to accomplish the activities of daily life, the future of obesity treatment will require the development of bodyweight reduction medications that work by a variety of mechanisms to decrease food intake or increase energy expenditure. Such medications should not be viewed as a 'crutch' but rather as a 'helping hand' that enable people to better adhere to a healthier lifestyle.
超重和肥胖在全球范围内呈上升趋势。在过去二十年中,美国成年人中较高体重指数(BMI)类别的患病率增长最为显著,BMI高于40kg/m²的人群患病率增长高达300%。在儿童和青少年中,严重超重患病率翻倍对未来可能患通常与衰老相关慢性病的年轻一代构成了严重健康风险。肥胖的简单定义是能量摄入与能量消耗失衡,但它忽略了基因、食物摄入和身体活动之间复杂且大多未知的相互作用,而这些因素共同决定体重和脂肪分布。尽管超重和肥胖的病因及表现复杂,但超重和肥胖的评估仅需准确测量体重、身高和腹围,以及针对超重和肥胖常见伴发疾病(如糖尿病、高血压、血脂异常和睡眠呼吸暂停)进行病史询问和体格检查。超重和肥胖患者的治疗仍基于饮食和身体活动的改变。忙碌的临床医生也可以采用简单的行为改变技术。额外使用现有的减肥药物可使体重从初始体重可靠地降低5%至10%,已证明这种体重减轻能带来显著的健康益处。使用代餐也已被证明是有效的,且可能是一种未得到充分重视的治疗手段。手术是重度肥胖患者最成功的治疗方法,对于合适体重类别的患者应作为一种选择进行讨论。由于社会趋势倾向于摄入更多高热量食物且减少用于日常生活活动的身体活动,肥胖治疗的未来将需要开发通过多种机制起作用以减少食物摄入或增加能量消耗的减肥药物。这类药物不应被视为“拐杖”,而应被视为能使人们更好地坚持更健康生活方式的“帮手”。